J Clin Endocrinol Metab · 2010
Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in HIV-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials
A pooled analysis of two phase-3 trials reported that tesamorelin reduced visceral adipose tissue in HIV patients with excess abdominal fat.
View on PubMed (PMID 20554713)